Navigating AI Regulation in Healthcare

This chapter explores the challenges and complexities involved in regulating AI in the healthcare sector, particularly focusing on the roles of organizations like the FDA. It emphasizes the necessity for high-quality data and collaboration between healthcare providers and tech companies to ensure effective testing and validation of AI models. The discussion also highlights the potential conflicts of interest that can arise from vendor funding in the evaluation process, underscoring the need for independent auditing and quality assurance.